Up to 30 percent of CVD mortality attributable to excess salt intake
Mar 29, 2024
The population-attributable risk estimates suggest that sodium above the recommended intake is linked to 10 to 30% of CVD mortality.
AHA: PREVENT risk calculator estimates risk for cardiovascular disease
Nov 13, 2023
PREVENT equations were developed and validated in adults aged 30 to 79 years without known CVD and included eGFR as a predictor.
FDA approves Wegovy to lower risk for CVD events in patients with obesity
Mar 08, 2024
Agency’s action could widen access to the drug if more insurance companies decide to cover it
Menopausal hormone therapy use beyond 65 years beneficial
Apr 16, 2024
Use of menopausal hormone therapy beyond age 65 years is associated with risk reductions in mortality as well as specific cancers and cardiovascular diseases, according to a study published online April...
Spring daylight savings transition tied to increase in cardiovascular events
Mar 14, 2024
The authors, however, say that there is a very low estimated probability that this association is of clinical importance.
Gains in heart health only experienced by higher-income populations
Apr 19, 2024
The 10-year risk for cardiovascular disease remained stagnant at >8% for US adults with the lowest incomes in 1988 to 2018.
Risks for all-cause, cardiovascular, respiratory mortality increased after floods
Oct 10, 2023
Risks vary by local climate type and socioeconomic status.
AHA: Daily marijuana use linked to incident heart failure
Nov 13, 2023
And cannabis use disorder is linked to an increased odds of major adverse cardiac and cerebrovascular events.
Medicare to cover Wegovy when patients also have heart disease
Mar 22, 2024
Medicare will now cover the popular weight-loss drug Wegovy if patients using it also have heart disease, US officials announced Thursday.
Few adults know their heart health numbers
Feb 13, 2024
Less than 20% of US adults know their cholesterol or blood sugar levels.